Table 2.
Studies available through 2012 evaluating response to ART across menopause in HIV-infected women.
|
Authors (year) |
Study design (followup) |
Menopause status | Number of women (total sample; n = 267) | Percent of total participants who were black/African American or Hispanic/Latina | CD4 cell counts in women after ART | HIV viral loads in women after ART | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measure | Results | P value | Measure | Results | P value | |||||
| Patterson et al. (2009) [36] | Cohort (2 years) |
Pre Post |
220 47 |
61% (black/AA) 17% (Hispanic) |
Increase in median CD4 from baseline | 260 (11.0%) 273 (12.0%) |
0.51 | Women achieving <50 copies/mL | 75% 77% |
>0.99 |
| Odds ratio of achieving <50 copies/mL for premenopausal women | 0.82 (0.36–1.89) |
NS | ||||||||
AA: African American, NS: not significant, Pre: premenopausal, Post: postmenopausal.